Skip to main content
SpringerLink
Log in

Spondyloarthritiden

  • Chapter
  • First Online:
Rheumatologie aus der Praxis

  • 4421 Accesses

Zusammenfassung

Unter Spondyloarthritiden versteht man entzündlich-rheumatische Erkrankungen, die einige typische klinische, serologische und genetische Gemeinsamkeiten aufweisen. Charakteristisch ist eine Beteiligung des Achsenskeletts, der Sehnenansätze im Sinne einer Enthesitis (z. B. ein Fersenschmerz) oder eine asymmetrische Oligoarthritis der unteren Extremitäten. Auch extraartikuläre Manifestationen wie eine Uveitis anterior sind häufig nachweisbar. Ihnen zugeordnet werden unter anderem die ankylosierende Spondylitis (Morbus Bechterew), die Psoriasisarthritis, die reaktiven Arthritiden und die enteropathischen Arthritiden. Der Beitrag beschreibt Gemeinsamkeiten und Unterschiede der angeführten Erkrankungen und informiert ausführlich über diagnostische und aktuelle therapeutische Schritte.

Das Fallbeispiel im Abschn. 3.6 („Ein 37-jähriger Mann mit Symptomen eines entzündlichen Rückenschmerzes”) wurde gekürzt übernommen aus: Puchner A, Winkler S (2016) Maltafieber. Fakten der Rheumatologie 4.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    Unter Mitarbeit von Antonia Puchner.

Literatur

  1. Amor B, Silva Santos R, Nahal R, Dougados M (1994) Predictive factors for the long term outcome of Spondyloarthropathies. J Rheumatol 21:1883–1887

    CAS  PubMed  Google Scholar 

  2. Baeten D, Sieper J, Braun J et al. (2015) Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534-48. doi: 10.1056/NEJMoa1505066

    Article  CAS  PubMed  Google Scholar 

  3. Baraliakos X, Braun J, (2015) Non-radiographic axial spondyloarthritis and ankylosing Spondylitis: what are the similarities and differences? RMD Open 1 (Suppl1):e000053. doi: 10.1136/rmdopen-2015-000053

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Behrens F, Thaci D, Wollenhaupt J, Krüger K. (2016) Psoriasisarthritis. Z Rheumatol 75:471-488

    Article  CAS  PubMed  Google Scholar 

  5. Bennett PH, Burch TA (1966) Population studies of the rheumatic diseases. Exerpta Medica Foundation, Amsterdam. International Congress Series 148:456-457

    Google Scholar 

  6. Blum U, Buitrago-Tellez C, Mundinger A et al. (1996) Magnetic resonance imaging (MRI) for detection of active sacroiliitis – a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 23:2107–2115

    CAS  PubMed  Google Scholar 

  7. Brandt J, Listing J, Haibel H et al. (2005) Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis. Rheumatology 44:342–348

    Article  Google Scholar 

  8. Braun J, Sieper J (2006) Spondyloarthritiden. Z Rheumatol 65:613–632

    Article  CAS  PubMed  Google Scholar 

  9. Braun J, Brandt J, Listing J et al. (2002) Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 359:1187–1193

    Article  CAS  PubMed  Google Scholar 

  10. Braun J, Davis J, Dougados M et al. (2006) First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 65:316–320

    Article  CAS  PubMed  Google Scholar 

  11. Braun J, van den Berg R, Baraklios X et al. (2011) 2010 Update of of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 70(6): 896–904

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Brown MA, Wordsworth BP, Reveille JD (2006) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 6 [Suppl 28] 20: S 43–49

    Google Scholar 

  13. Brzank M, Wollenhaupt J (2013) Infektinduzierte reactive Arthritiden. Z Rheumatol 72:977–985

    Article  CAS  PubMed  Google Scholar 

  14. Calin A (1984) Reiter’s Syndrome. In: Calin A (Hrsg) Spondyloarthropathies. Grune & Stratton, Orlando, FL, S 844–849

    Google Scholar 

  15. Calin A, Porta J, Fries JF, Schurmann DJ (1977) Clinical history as a screening test for ankylosing spondylitis. JAMA 237(24): 2613–2614

    Article  CAS  PubMed  Google Scholar 

  16. Calin A, Garret S, Whitelock H et al. (1994) A new approach to defining functional ability in ankolysing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  17. Cauza E, Dunky A (2006) Psoriasis Arthritis. Wien Med Wochenschr 156:587–595

    Article  PubMed  Google Scholar 

  18. Chandran V, Schentag CT, Gladman DD (2007) Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 57:1560–1563

    Article  PubMed  Google Scholar 

  19. Clegg DO, Reda DJ, Mejias E et al. (1996) Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs cooperative study. Arthritis Rheum 39:2013–2020

    CAS  PubMed  Google Scholar 

  20. Coates LC, Murphy R, Helliwell PS (2016) New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation. Br J Dermatol 174(6):1174–1178. doi: 10.1111/bjd.14667

    Article  CAS  PubMed  Google Scholar 

  21. Dagfinrud H, Kvien TK, Hagen KB (2008) Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev 1: CD002822 18254008

    Google Scholar 

  22. Dallek R (2003) John F. Kennedy. Ein unvollendetes Leben. DVA, München

    Google Scholar 

  23. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al. (1991) The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum 34:1218–1227

    Article  CAS  PubMed  Google Scholar 

  24. Ebner W (2008) Therapieoptionen bei Morbus Bechterew. J Miner Stoffwechs 15:84–88

    Google Scholar 

  25. Ebner W (2008) Früherkennung des Morbus Bechterew in der allgemeinmedizinischen Praxis ÖGAM Newsletter 4

    Google Scholar 

  26. Falkenbach A ed (2005) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York

    Google Scholar 

  27. Finzel S, Englbrecht M (2011) Psoriasisarthritis. Z Rheumatol 70:775–789

    Article  CAS  PubMed  Google Scholar 

  28. Garret S, Jenkinson T, Kennedy LG, et al. (1994) A new approach to defining disease status in ankolysing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291

    Google Scholar 

  29. Genth E (2008) Arthritiden bei gastrointestinalen Erkrankungen. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Aufl. Springer, Berlin Heidelberg New York, S 554–559

    Google Scholar 

  30. Genth E (2008) Arthritis psoriatica und Arthritis bei gastrointestinalen Grundkrankheiten. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Aufl. Springer, Berlin Heidelberg New York, S 547–553

    Chapter  Google Scholar 

  31. Gladman DD, Antoni C, Mease P et al. (2005) Psoriatic arthritis: Epidemiology, clinical features, course and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17

    PubMed  PubMed Central  Google Scholar 

  32. Gossec L1, Smolen JS, Ramiro S et al. (2016) European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. Ann Rheum Dis 75(3):499–510. doi: 10.1136/annrheumdis-2015-208337

    Article  CAS  PubMed  Google Scholar 

  33. Haibel H, Rudwaleit M, Braun J, Sieper J (2002) Epidemiologie und Versorgung im Bereich der Spondyloarthropathien. Z Rheumatol 61:30–38

    Article  CAS  PubMed  Google Scholar 

  34. Haibel H, Rudwaleit M, Sieper J, Zeidler H, Kuipers JG (2004) Diagnostik der reaktiven Arthritis. Z Rheumatol 63:211–215

    CAS  PubMed  Google Scholar 

  35. Huber AJ, Manger B (2013) Neues zur Pathogenese der Psoriasisarthritis. Z Rheumatol 72: 758–763

    Article  Google Scholar 

  36. Kappelman MD, Rifas-Shiman SL, Kleinman K et al. (2007) The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 5:1424–1429

    Article  PubMed  Google Scholar 

  37. Kvien TK, Glennas A, Melby K, Granfors K, Andrup O, Karstensen B, Thoen JE (1994) Reactive arthritis: Incidence, triggering agents and clinical presentation. J Rheumatol 21:115–122

    CAS  PubMed  Google Scholar 

  38. Langer H-E (2008) Biologicals in der frühen Behandlung des M. Bechterew und verwandter Spondyloarthritiden. Wien Med Wochenschr 158:200–205

    Article  Google Scholar 

  39. Manger B (2005) Checkliste XXL Rheumatologie, 3. Aufl. Thieme, Stuttgart

    Google Scholar 

  40. Märker-Hermann E, Behrens F (2009) Psoriasisarthritis: Zielkriterien der Behandlung. Z Rheumatol 68:16–22

    Article  PubMed  Google Scholar 

  41. Mau W, Zeidler H (2008) Sonstige entzündliche Spondylopathien. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Aufl. Springer, Berlin Heidelberg New York, S 923–928

    Google Scholar 

  42. Mau W, Zeidler H (2008) Spondylitis ankylosans. In: Zeidler H Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Auflage. Springer, Berlin Heidelberg New York, S 907–923

    Chapter  Google Scholar 

  43. Miehle W, Fehr K, Schattenkirchner M, Tillmann K (2000) Arthritis bei Zöliakie. In: Rheumatologie in Praxis und Klinik, 2. Aufl. Thieme, Stuttgart, S 709

    Google Scholar 

  44. Mielants H, Veys EM, Cuvelier C et al. (1995) The evolution of spondylarthropathies in relation to gut history: II. Histological aspects. J Rheumatol 22:2273–2278

    CAS  PubMed  Google Scholar 

  45. Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:51–78

    Article  Google Scholar 

  46. Mumtaz A, Gallaher P, Kirby B et al. (2011) Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis 70:272–277

    Article  PubMed  Google Scholar 

  47. Nell Duxneuner P, Stamm T, Aletaha D et al. (2007) Measures associated with disease activity in psoriatic arthritis. Arthritis Rheum 56 [Suppl]: 481

    Google Scholar 

  48. Orchard TR, Wordsworth BP, Jwell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Picozzi M, Weber M, Frey RA, Baumberger H (2002) Spondylitis ankylosans (M. Bechterew): Frühdiagnose und das bunte Bild der Krankheit. Schweiz Med Forum 2:232–237

    Google Scholar 

  50. Puchner R (2008) J. F. Kennedy. In: Loisl D, Puchner R (Hrsg) Diagnose Rheuma, 2. Aufl. Springer, Wien New York, S 136

    Google Scholar 

  51. Puchner A, Winkler S (2016) Maltafieber. Fakt Rheumatol 4 (in Druck)

    Google Scholar 

  52. Puchner R, Edlinger M, Mur E et al. (2016) Interface management between general practitioners and rheumatologists –Results of a survey defining a concept for future joint recommendations. PLoS One 11(1):e0146149. doi: 10.1371/journal.pone.0146149

    Article  PubMed  PubMed Central  Google Scholar 

  53. Rainer F, Rudwaleit M (2005) Diagnosestellung. In: Falkenbach A (Hrsg) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York, S 23–54

    Chapter  Google Scholar 

  54. Ramiro S, Smolen JS, Landewé R et al. (2016) Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis. Ann Rheum Dis.75(3):490-8. doi: 10.1136/annrheumdis-2015-208466

    Article  CAS  PubMed  Google Scholar 

  55. Ritchlin CT, Kavanaugh A, Gladman D et al. (2008) Treatment recommendation for psoriatic arthritis. Arthritis Rheum 58 (Suppl):363–364

    Google Scholar 

  56. Ronneberger M (2009) Enteropathische Arthritis. Z Rheumatol 68:329–336

    Article  CAS  PubMed  Google Scholar 

  57. Rudwaleit M, Sieper J (2005) Diagnose und Frühdiagnose der Spondylitis ankylosans (Morbus Bechterew). Morbus Bechterew J 26:4–9

    Google Scholar 

  58. Rudwaleit M, Sieper J (2005) Frühdiagnose von Spondyloarthritiden mit besonderer Betonung auf die axialen Formen. Z Rheumatol 64:524–530

    Article  CAS  PubMed  Google Scholar 

  59. Rudwaleit M, Metter A, Listing J et al. (2002) Clinical parameters in the differentiation of inflammatory back pain from non-inflammatory back pain. Ann Rheum Dis 61(Suppl 1):57

    Google Scholar 

  60. Rudwaleit M, Listing J, Brandt J Braun J, Sieper J (2004) Prediction of a major clinical response (BASDAI 50) to tumour necrosis factor alpha blockers in ankylosing spondylitis. Ann Rheum Dis 63:665–70

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Rudwaleit M, Feldtkeller E, Sieper J (2006) Easy assessment of axial spondyloarthritis (early ankylosing spondylitis) at the bedside. Ann Rheum Dis 65:1251–1252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Rudwaleit M, Metter A, Listing J et al. (2006) Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54:569–578

    Article  Google Scholar 

  63. Rudwaleit M, Braun J, Sieper J (2009) ASAS-Klassifkationskriterien für axiale Spondyloarthritis. Z Rheumatol 68:591–593

    Article  CAS  PubMed  Google Scholar 

  64. Rudwaleit M. et al. (2009) Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group. Ann Rheum Dis 68:1520–1527. doi:10.1136/ard.2009.110767.

    CAS  PubMed  Google Scholar 

  65. Rudwaleit M, Landewé R, van der Heijde D et al. (2009) The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondyloarthritis (part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis 68:770–776

    Article  CAS  PubMed  Google Scholar 

  66. Rudwaleit M, van der Heijde D, Landewé R et al. (2009) The development of Assessment of Spondylo Arthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783

    Article  CAS  PubMed  Google Scholar 

  67. Rudwaleit M et al. (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70:25-31. doi:10.1136/ard.2010.133645

    Article  CAS  PubMed  Google Scholar 

  68. Schnarr S, Jendro M. C. Wollenhaupt J, Zeidler H (2008) Reaktive Arthritiden. In: Zeidler H, Zache J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie, 2. Aufl. Springer, Berlin Heidelberg New York, S 461–480

    Chapter  Google Scholar 

  69. Schoels MM, Aletaha D, Alasti F et al. (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75(5):811–818

    Article  PubMed  Google Scholar 

  70. Schueller-Weidekamm C. et al. (2014) Imaging and interpretation of axial spondylarthritis: the radiologist's perspective – consensus of the Arthritis Subcommittee of the ESSR. Sem Musculoskeletal Radiol 18:265–279. doi:10.1055/s-0034-1375569.

    Google Scholar 

  71. Sieper J, Fendler C, Laitko S, Sorensen H, Gripenberg-Lerche C, Hiepe F, Alten R, Keitel W, Groh A, Uksila J, Eggens U, Granfors K, Braun J (1999) No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebocontrolled study. Arthritis Rheum 42:1386–1396

    Article  CAS  PubMed  Google Scholar 

  72. Sieper J, Braun J, Rudwaleit M et al. (2002) Ankylosing spondylitis: an overview. Ann Rheum Dis 61 [Suppl 3]: iii8–18

    Article  PubMed  PubMed Central  Google Scholar 

  73. Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327

    Article  PubMed  Google Scholar 

  74. Sieper J, Rudwaleit M, Khan MA, Braun J (2006) Concepts and epidemiology of spondylarthritis. Best Pract Res Clin Rheumatol 20:401–417

    Article  PubMed  Google Scholar 

  75. Sieper J, van der Heijde D, Landewé R et al. (2009) New criteria for inflammatory back pain in patients with chronic back pain: A real patient exercise by experts from the Assessment of Spondylo Arthritis international Society (ASAS). Ann Rheum Dis 68:784–788

    Article  CAS  PubMed  Google Scholar 

  76. Stein J (2004) Gastrointestinale Komplikationen. In: Falkenbach A (Hrsg) Morbus Bechterew, S 211–245

    Google Scholar 

  77. Taylor W, Gladman D, Helliwell P et al. (2006) Classification criteria for psoriatic arthritis: Development of new criteria from a large international study. Arthritis Rheum 54:2665–2673

    Article  PubMed  Google Scholar 

  78. Van der Heijde D, Sieper J, Maksymowych WP et al. (2011) Assessment of Spondylo Arthritis international Society. 2010 Update of the international ASAS recommendations for the use of anti TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70(6): 905–908

    Article  PubMed  Google Scholar 

  79. Van der Linden S, Falkenbach A (2005) Prognose. In: Falkenbach A (Hrsg) Morbus Bechterew, Beratung, Betreuung, Behandlung. Springer, Wien New York, S 71–81

    Chapter  Google Scholar 

  80. Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    CAS  PubMed  Google Scholar 

  81. Zochling J, Brandt J, Braun J (2005) The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology 44:1483–1491

    Article  CAS  PubMed  Google Scholar 

  82. Zochling J, van der Heijde D, Burgos-Vargas R et al. (2006) ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 65:442–452

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internist und Rheumatologe, Freiung 19, 4600, Wels, Österreich

    Rudolf Puchner

Authors
  1. Rudolf Puchner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rudolf Puchner .

Editor information

Editors and Affiliations

  1. Wels, Austria

    Rudolf Puchner

Rights and permissions

Reprints and permissions

Copyright information

© 2017 © Springer-Verlag GmbH Deutschland

About this chapter

Cite this chapter

Puchner, R. (2017). Spondyloarthritiden. In: Puchner, R. (eds) Rheumatologie aus der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-53569-1_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-53569-1_3

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-53568-4

  • Online ISBN: 978-3-662-53569-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation